| 摘要 |
FIELD: molecular biology, blood proteins. SUBSTANCE: invention relates to erythropoietin analogs involving at least one additional site for glycosylation, or rearrangement of at least one site for glycosylation. Invention involves also DNA sequences encoding the indicated analogs of erythropoietin, recombinant plasmids, and host-cells for analog expression. EFFECT: enhanced effectiveness of analogs. |
